Brain, Vol. 122, No. 8, 1437-1448,
August 1999
© 1999 Oxford University Press
The substantia nigra of the human brain
II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
1 INSERM U289, Hôpital de la Salpêtrière, Paris, France and 2 Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Correspondence to:
Dr P. Damier, INSERM U289, Hôpital de la Salpêtrière, 47, boulevard de l'hôpital, 75013 Paris, France E-mail: cic.salpetriere{at}psl.ap-hop-paris.fr
To achieve accuracy in studying the patterns of loss of midbrain dopamine-containing neurons in Parkinson's disease, we used compartmental patterns of calbindin D28K immunostaining to subdivide the substantia nigra with landmarks independent of the degenerative process. Within the substantia nigra pars compacta, we identified dopamine-containing neurons in the calbindin-rich regions (`matrix') and in five calbindin-poor pockets (`nigrosomes') defined by analysis of the three-dimensional networks formed by the calbindin-poor zones. These zones were recognizable in all of the brains, despite severe loss of dopamine-containing neurons. The degree of loss of dopamine-containing neurons in the substantia nigra pars compacta was related to the duration of the disease, and the cell loss followed a strict order. The degree of neuronal loss was significantly higher in the nigrosomes than in the matrix. Depletion was maximum (98%) in the main pocket (nigrosome 1), located in the caudal and mediolateral part of the substantia nigra pars compacta. Progressively less cell loss was detectable in more medial and more rostral nigrosomes, following the stereotyped order of nigrosome 1 > nigrosome 2 > nigrosome 4 > nigrosome 3 > nigrosome 5. A parallel, but lesser, caudorostral gradient of cell loss was observed for dopamine-containing neurons included in the matrix. This pattern of neuronal loss was consistent from one parkinsonian substantia nigra pars compacta to another. The spatiotemporal progression of neuronal loss related to disease duration can thus be drawn in the substantia nigra pars compacta for each Parkinson's disease patient: depletion begins in the main pocket (nigrosome 1) and then spreads to other nigrosomes and the matrix along rostral, medial and dorsal axes of progression.
Parkinson's disease; dopamine; calbindin; substantia nigra; basal ganglia
TH = tyrosine hydroxylase
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Joksimovic, A. Anderegg, A. Roy, L. Campochiaro, B. Yun, R. Kittappa, R. McKay, and R. Awatramani Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools PNAS, November 10, 2009; 106(45): 19185 - 19190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jokinen, H. Helenius, E. Rauhala, A. Bruck, O. Eskola, and J. O. Rinne Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls J. Nucl. Med., June 1, 2009; 50(6): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lees The Parkinson chimera Neurology, February 17, 2009; 72(7_Supplement_2): S2 - S11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. B. Wisman, G. Sahin, M. Maingay, G. Leanza, and D. Kirik Functional Convergence of Dopaminergic and Cholinergic Input Is Critical for Hippocampus-Dependent Working Memory J. Neurosci., July 30, 2008; 28(31): 7797 - 7807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Plaha, S Filipovic, and S S Gill Induction of parkinsonian resting tremor by stimulation of the caudal zona incerta nucleus: a clinical study J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 514 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kaiser Brain architecture: a design for natural computation Phil Trans R Soc A, December 15, 2007; 365(1861): 3033 - 3045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Akkal, R. P. Dum, and P. L. Strick Supplementary Motor Area and Presupplementary Motor Area: Targets of Basal Ganglia and Cerebellar Output J. Neurosci., October 3, 2007; 27(40): 10659 - 10673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Breysse, T. Carlsson, C. Winkler, A. Bjorklund, and D. Kirik The Functional Impact of the Intrastriatal Dopamine Neuron Grafts in Parkinsonian Rats Is Reduced with Advancing Disease J. Neurosci., May 30, 2007; 27(22): 5849 - 5856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Saraf, D. M. Virshup, and S. Strack Differential Expression of the B'beta Regulatory Subunit of Protein Phosphatase 2A Modulates Tyrosine Hydroxylase Phosphorylation and Catecholamine Synthesis J. Biol. Chem., January 5, 2007; 282(1): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sgado, L. Alberi, D. Gherbassi, S. L. Galasso, G. M. J. Ramakers, K. N. Alavian, M. P. Smidt, R. H. Dyck, and H. H. Simon Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice PNAS, October 10, 2006; 103(41): 15242 - 15247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Easton and C. A. Marsden Ecstasy: Are animal data consistent between species and can they translate to humans? J Psychopharmacol, March 1, 2006; 20(2): 194 - 210. [Abstract] [PDF]
|
|
|
|
|
|
J. W. Um, D. S. Min, H. Rhim, J. Kim, S. R. Paik, and K. C. Chung Parkin Ubiquitinates and Promotes the Degradation of RanBP2 J. Biol. Chem., February 10, 2006; 281(6): 3595 - 3603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Piccini, N. Pavese, P. Hagell, J. Reimer, A. Bjorklund, W. H. Oertel, N. P. Quinn, D. J. Brooks, and O. Lindvall Factors affecting the clinical outcome after neural transplantation in Parkinson's disease Brain, December 1, 2005; 128(12): 2977 - 2986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Halliday, A. Ophof, M. Broe, P. H. Jensen, E. Kettle, H. Fedorow, M. I. Cartwright, F. M. Griffiths, C. E. Shepherd, and K. L. Double {alpha}-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease Brain, November 1, 2005; 128(11): 2654 - 2664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Y. Chung, H. Seo, K. C. Sonntag, A. Brooks, L. Lin, and O. Isacson Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum. Mol. Genet., July 1, 2005; 14(13): 1709 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. C. Baquet, P. C. Bickford, and K. R. Jones Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta J. Neurosci., June 29, 2005; 25(26): 6251 - 6259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Norris, B. I. Giasson, R. Hodara, S. Xu, J. Q. Trojanowski, H. Ischiropoulos, and V. M.-Y. Lee Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations J. Biol. Chem., June 3, 2005; 280(22): 21212 - 21219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Giasson Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease? Sci. Aging Knowl. Environ., December 1, 2004; 2004(48): pe42 - pe42. [Abstract] [Full Text]
|
|
|
|
|
|
B A Racette, G J Esper, J Antenor, K J Black, A Burkey, S M Moerlein, T O Videen, V Kotagal, J G Ojemann, and J S Perlmutter Pathophysiology of parkinsonism due to hydrocephalus J. Neurol. Neurosurg. Psychiatry, November 1, 2004; 75(11): 1617 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Huynh, D. R. Scoles, D. Nguyen, and S. M. Pulst The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI Hum. Mol. Genet., October 16, 2003; 12(20): 2587 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Crocker, P. D. Smith, V. Jackson-Lewis, W. R. Lamba, S. P. Hayley, E. Grimm, S. M. Callaghan, R. S. Slack, E. Melloni, S. Przedborski, et al. Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease J. Neurosci., May 15, 2003; 23(10): 4081 - 4091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quik, J. D. Sum, P. Whiteaker, S. E. McCallum, M. J. Marks, J. Musachio, J. M. Mcintosh, A. C. Collins, and S. R. Grady Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice Mol. Pharmacol., May 1, 2003; 63(5): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. de Erausquin, K. Hyrc, D. A. Dorsey, D. Mamah, M. Dokucu, D. H. Masco, T. Walton, K. Dikranian, M. Soriano, J. M. G. Verdugo, et al. Nuclear Translocation of Nuclear Transcription Factor-kappa B by alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Leads to Transcription of p53 and Cell Death in Dopaminergic Neurons Mol. Pharmacol., April 1, 2003; 63(4): 784 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nunes, L. T. Tovmasian, R. M. Silva, R. E. Burke, and S. P. Goff Pitx3 is required for development of substantia nigra dopaminergic neurons PNAS, April 1, 2003; 100(7): 4245 - 4250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Junn, R. D. Ronchetti, M. M. Quezado, S.-Y. Kim, and M. M. Mouradian Tissue transglutaminase-induced aggregation of alpha -synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies PNAS, February 18, 2003; 100(4): 2047 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grotzsch, G.-P. Pizzolato, J. Ghika, D. Schorderet, F.J. Vingerhoets, T. Landis, and P.R. Burkhard Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14 Neurology, June 25, 2002; 58(12): 1839 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Mouradian Recent advances in the genetics and pathogenesis of Parkinson disease Neurology, January 22, 2002; 58(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, S. Chalon, D. Guilloteau, A. R. Crossman, B. Bioulac, J. M. Brotchie, and C. E. Gross Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease J. Neurosci., September 1, 2001; 21(17): 6853 - 6861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sawamoto, N. Nakao, K. Kakishita, Y. Ogawa, Y. Toyama, A. Yamamoto, M. Yamaguchi, K. Mori, S. A. Goldman, T. Itakura, et al. Generation of Dopaminergic Neurons in the Adult Brain from Mesencephalic Precursor Cells Labeled with a nestin-GFP Transgene J. Neurosci., June 1, 2001; 21(11): 3895 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Liu, J.-W. Jiang, B. C. Wilson, L. Du, S.-N. Yang, J.-Y. Wang, G.-C. Wu, X.-D. Cao, and J.-S. Hong Systemic Infusion of Naloxone Reduces Degeneration of Rat Substantia Nigral Dopaminergic Neurons Induced by Intranigral Injection of Lipopolysaccharide J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 125 - 132. [Abstract] [Full Text]
|
|
|
|
 |
|
 The Neuroscientist Comments Neuroscientist, April 1, 2000; 6(2): 69 - 72. [PDF]
|
|
|
|
|
|
C. B. Saper `Like a thief in the night' : the selectivity of degeneration in Parkinson's disease Brain, August 1, 1999; 122(8): 1401 - 1402. [Full Text] [PDF]
|
|
|
|
|
|
A. Hartmann, S. Hunot, P. P. Michel, M.-P. Muriel, S. Vyas, B. A. Faucheux, A. Mouatt-Prigent, H. Turmel, A. Srinivasan, M. Ruberg, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease PNAS, March 14, 2000; 97(6): 2875 - 2880. [Abstract] [Full Text] [PDF]
|
|